The Ethics of Psychedelic-Assisted Therapies by Dr Simon Longstaff AO
Few measures better reveal the character of a society than its approach to those who suffer. Occasionally, the suffering we encounter is beyond our capacity to relieve. In those cases, we can be held to no higher standard than that we have responded with care and compassion.
Mind Medicine Australia celebrates its First Anniversary by Tania de Jong AM
Today, Mind Medicine Australia turns one year old! In our first year, we have made remarkable progress in growing public awareness of Medicine-Assisted Therapy in Australia.
MDMA-assisted psychotherapy for post-traumatic stress disorder (PTSD) by Melissa Warner and Paul Liknaitzky
In the treatment of PTSD, both pharmacotherapy and psychotherapy present additional challenges. PTSD is notoriously hard to treat, with current anti-depressant pharmacotherapy achieving relief from symptoms in about 20%-30% of sufferers.
Breaking Convention: The next steps for psychedelic-assisted therapy by Melissa Warner
With great promise, and the growing hopes of many, comes a need for foresight and acumen in the psychedelic research community. To better forecast the emerging science and international mood, I journeyed to Breaking Convention, Europe’s largest psychedelic science conference.
Letter from Dr Simon Longstaff AO, Director, Mind Medicine Australia
My hope for Mind Medicine Australia (MMA) is that it will play a direct role in reducing the incidence of avoidable suffering in Australia. I think we are obliged to reduce harm in the world by pursuing ends that are good through means that are right.